Search PubMed⌕ Search

Biomedical subjects

M Kamel

Publications and source records attributed to M Kamel.

89 records · Page 5Linked to original sources
PubMedDate not supplied

Inhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine.

We studied the effect of aminosugars on the elastase enzyme released from cytochalasin-B treated polymorphonuclear neutrophils (PMN) and stimulated by F-Met-Leu-Phe (FMLP). Both N-acetyl-galactosamine and N-acetyl-glucosamine can inhibit the release of leukocyte elastase enzyme. N-acetyl-galactosamine was a potent inhibitor of elastase enzyme release in a dose-related fashion. Inhibition ranged from 91.9% up to total inhibition. N-acetyl-glucosamine showed a mild inhibitory effect on elastase enzyme release; however, it too acted in a dose-related fashion. The range of inhibition was 17.17%-8.18%. Mannosamine showed an inhibitory effect in some donors, but this effect was not statistically significant. No effect on elastase enzyme release was shown with other sugars such as D-glucose and L-fucose. These results show that N-acetyl-galactosamine can inhibit the respiratory burst, which suggests that the aminosugars might do more than interfere with the carbohydrate lectin interaction.

Acetylgalactosamine↗
PubMedDate not supplied

Fucose concentrations in sera from patients with rheumatoid arthritis.

The clinical significance of L-fucose was investigated in serum of a well characterized cohort of 135 RA patients and 60 healthy controls. In RA patients, serum L-fucose was significantly decreased to a mean of 5.57 +/- 0.97 mg%, (range 2.2-7.5 mg%), compared with 7.5 +/- 1.04 mg% (range 5.7-9.8 mg%) (p < 0.001) in normal controls. In early RA serum L-fucose was significantly depressed to a mean of 6.08 mg%, a value which was significantly higher than the mean concentration of L-fucose in patients with advanced RA. Serum L-fucose was significantly correlated with the rheumatoid disease activity, duration, number of involved joints, and bone erosions. No statistically significant difference was found between seropositive and seronegative RA patients. However, a significant difference (p < 0.001) between female (5.57 mg%) and male (6.59 mg%) patients with advanced RA, and between male (6.08 mg%) and female (5.99 mg%) patients with early RA was found. These findings suggest that serum L-fucose is depressed in patients with rheumatoid arthritis, a promising observation since L-fucose is a safe and simple natural sugar. It may be used as an additional parameter and as an indicator for the disease activity in the follow up of patients with rheumatoid arthritis.

Adolescent↗